Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer

Muscle invasive bladder cancer (MIBC) is an aggressive disease that frequently requires radical cystectomy (RC) to achieve durable cure rates. Surgery is most effective when performed in organ-confined disease, with the best outcomes for those patients with a pT0 result. The goals of neoadjuvant che...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayaratna, Isuru S., Navai, Neema, Dinney, Colin P. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708231/
https://www.ncbi.nlm.nih.gov/pubmed/26816830
http://dx.doi.org/10.3978/j.issn.2223-4683.2015.06.07

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708231/
https://www.ncbi.nlm.nih.gov/pubmed/26816830
http://dx.doi.org/10.3978/j.issn.2223-4683.2015.06.07

Ejemplares similares